AKT1 and leukemia: Schubbert S et al revealed that targeting MYC and PI3K pathway could eliminate leukemia‐initiating cells in T‐ALL.33 Moyo et al showed that MYC is overexpressed in pre‐malignant B cells with activation of PI3K/AKT signaling pathway.